ISSN
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration SRAS - Checkpoint (Ncbi)

Index « ISSN » - entrée « 0968-0896 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0967-070X < 0968-0896 < 0968-4328  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000012 (2001) C E Stephens [États-Unis] ; T M Felder ; J W Sowell ; G. Andrei ; J. Balzarini ; R. Snoeck ; E. De ClercqSynthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones.
000013 (2001) D J Hwang [Corée du Sud] ; S N Kim ; J H Choi ; Y S LeeDicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors.
000372 (2003) Andreas J. Kesel [Allemagne]A system of protein target sequences for anti-RNA-viral chemotherapy by a vitamin B6-derived zinc-chelating trioxa-adamantane-triol.
000748 (2004) Xue Wu Zhang [République populaire de Chine] ; Yee Leng YapExploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design.
000D46 (2005) Naoyuki Masuda [Japon] ; Osamu Yamamoto ; Masahiro Fujii ; Tetsuro Ohgami ; Jiro Fujiyasu ; Toru Kontani ; Ayako Moritomo ; Masaya Orita ; Hiroyuki Kurihara ; Hironobu Koga ; Shunji Kageyama ; Mitsuaki Ohta ; Hiroshi Inoue ; Toshifumi Hatta ; Masafumi Shintani ; Hiroshi Suzuki ; Kenji Sudo ; Yasuaki Shimizu ; Eiichi Kodama ; Masao Matsuoka ; Masatoshi Fujiwara ; Tomoyuki Yokota ; Shiro Shigeta ; Masanori BabaStudies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives.
001520 (2006) Xingnan Li [États-Unis] ; Robert VinceSynthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
001737 (2006) Lili Chen [République populaire de Chine] ; Jian Li ; Cheng Luo ; Hong Liu ; Weijun Xu ; Gang Chen ; Oi Wah Liew ; Weiliang Zhu ; Chum Mok Puah ; Xu Shen ; Hualiang JiangBinding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features.
001A52 (2007) Masahiro Ikejiri [Japon] ; Takayuki Ohshima ; Keizo Kato ; Masaaki Toyama ; Takayuki Murata ; Kunitada Shimotohno ; Tokumi Maruyama5'-O-masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents.
001B98 (2008) Yi-Ming Shao [Taïwan] ; Wen-Bin Yang [Taïwan] ; Tun-Hsun Kuo [Taïwan] ; Keng-Chang Tsai [Taïwan] ; Chun-Hung Lin [Taïwan] ; An-Suei Yang [Taïwan] ; Po-Huang Liang [Taïwan] ; Chi-Huey Wong [Taïwan, États-Unis]Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
001C01 (2008) Prasenjit Mukherjee [États-Unis] ; Prashant Desai [États-Unis] ; Larry Ross [États-Unis] ; E. Lucile White [États-Unis] ; Mitchell A. Avery [États-Unis]Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits
001D64 (2008) Kenichi Akaji [Japon] ; Hiroyuki Konno [Japon] ; Mari Onozuka [Japon] ; Ayumi Makino [Japon] ; Hiroyuki Saito [Japon] ; Kazuto Nosaka [Japon]Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant
002794 (2013) Wei Liu [République populaire de Chine] ; He-Min Zhu [République populaire de Chine] ; Guo-Jun Niu [République populaire de Chine] ; En-Zhi Shi [République populaire de Chine] ; Jie Chen [République populaire de Chine] ; Bo Sun [République populaire de Chine] ; Wei-Qiang Chen [République populaire de Chine] ; Hong-Gang Zhou [République populaire de Chine] ; Cheng Yang [République populaire de Chine]Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors
002798 (2013) Hyun Lee ; Anuradha Mittal ; Kavankumar Patel ; Joseph L. Gatuz ; Lena Truong ; Jaime Torres ; Debbie C. Mulhearn ; Michael E. JohnsonIdentification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings
002A16 (2014) Yasuhiro Shimamoto [Japon] ; Yasunao Hattori [Japon] ; Kazuya Kobayashi [Japon] ; Kenta Teruya [Japon] ; Akira Sanjoh [Japon] ; Atsushi Nakagawa [Japon] ; Eiki Yamashita [Japon] ; Kenichi Akaji [Japon]Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
002B00 (2015) Sarah E. St. John [États-Unis] ; Sakshi Tomar [États-Unis] ; Shaun R. Stauffer [États-Unis] ; Andrew D. Mesecar [États-Unis]Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4—The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS)
002C03 (2016) Hiroyuki Konno [Japon] ; Masaki Wakabayashi [Japon] ; Daiki Takanuma [Japon] ; Yota Saito [Japon] ; Kenichi Akaji [Japon]Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/ISSN.i -k "0968-0896" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/ISSN.i  \
                -Sk "0968-0896" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0968-0896
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021